Sandra A N Walker

1.3k total citations
45 papers, 863 citations indexed

About

Sandra A N Walker is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Sandra A N Walker has authored 45 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Applied Microbiology and Biotechnology and 13 papers in Pharmacology. Recurrent topics in Sandra A N Walker's work include Antibiotic Use and Resistance (16 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Sandra A N Walker is often cited by papers focused on Antibiotic Use and Resistance (16 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Sandra A N Walker collaborates with scholars based in Canada, United States and France. Sandra A N Walker's co-authors include Marion Elligsen, Andrew E. Simor, Nick Daneman, Lesley Palmay, Samira Mubareka, Ruxandra Pinto, Jerome A. Leis, Vanessa Allen, Scott E. Walker and Alex Kiss and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sandra A N Walker

44 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra A N Walker Canada 16 357 341 181 169 162 45 863
Lesley Palmay Canada 10 360 1.0× 218 0.6× 132 0.7× 89 0.5× 123 0.8× 20 607
Marion Elligsen Canada 19 653 1.8× 481 1.4× 246 1.4× 200 1.2× 294 1.8× 49 1.2k
Jason P. Burnham United States 16 197 0.6× 219 0.6× 96 0.5× 151 0.9× 143 0.9× 50 892
Kathryn Dzintars United States 11 382 1.1× 320 0.9× 187 1.0× 184 1.1× 160 1.0× 31 862
Russell M. Petrak United States 12 310 0.9× 249 0.7× 316 1.7× 229 1.4× 112 0.7× 22 871
Peter Zarb Malta 12 606 1.7× 400 1.2× 126 0.7× 270 1.6× 114 0.7× 23 1.1k
Kalvin Yu United States 18 338 0.9× 428 1.3× 98 0.5× 253 1.5× 151 0.9× 72 965
Bernard Camins United States 20 268 0.8× 331 1.0× 82 0.5× 628 3.7× 278 1.7× 59 1.2k
Sorabh Dhar United States 18 214 0.6× 239 0.7× 236 1.3× 222 1.3× 134 0.8× 55 931
Timothy C Jenkins United States 20 509 1.4× 510 1.5× 138 0.8× 645 3.8× 474 2.9× 88 1.4k

Countries citing papers authored by Sandra A N Walker

Since Specialization
Citations

This map shows the geographic impact of Sandra A N Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A N Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A N Walker more than expected).

Fields of papers citing papers by Sandra A N Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A N Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A N Walker. The network helps show where Sandra A N Walker may publish in the future.

Co-authorship network of co-authors of Sandra A N Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A N Walker. A scholar is included among the top collaborators of Sandra A N Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A N Walker. Sandra A N Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Walker, Sandra A N, et al.. (2020). Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults. European Journal of Clinical Pharmacology. 77(2). 197–205. 6 indexed citations
3.
Walker, Sandra A N, et al.. (2019). Voriconazole prophylaxis in leukemic patients: A retrospective single-center study. Journal of Oncology Pharmacy Practice. 26(4). 873–881. 6 indexed citations
4.
Walker, Sandra A N, et al.. (2019). Optimizing gentamicin conventional and extended interval dosing in neonates using Monte Carlo simulation – a retrospective study. BMC Pediatrics. 19(1). 318–318. 9 indexed citations
5.
Walker, Sandra A N, et al.. (2019). Development, evaluation and validation of a screening tool for late onset bacteremia in neonates – a pilot study. BMC Pediatrics. 19(1). 253–253. 5 indexed citations
6.
Walker, Sandra A N, et al.. (2018). The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study. BMC Pharmacology and Toxicology. 19(1). 47–47. 3 indexed citations
7.
Lee, Colin, Sandra A N Walker, Lesley Palmay, et al.. (2018). Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief Report. Peritoneal Dialysis International. 38(1). 73–76. 3 indexed citations
8.
Lee, Colin, Sandra A N Walker, Scott E. Walker, et al.. (2017). A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients. Burns. 43(8). 1766–1774. 12 indexed citations
9.
Leis, Jerome A., Lesley Palmay, Sumit Raybardhan, et al.. (2017). Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation. Clinical Infectious Diseases. 65(7). 1059–1065. 45 indexed citations
10.
Walker, Sandra A N, Marion Elligsen, Nicole Mittmann, et al.. (2015). Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. Journal of Hospital Infection. 92(1). 33–41. 53 indexed citations
11.
Walker, Sandra A N, et al.. (2015). Outcomes in Documented Pseudomonas aeruginosa Bacteremia Treated with Intermittent IV Infusion of Ceftazidime, Meropenem, or Piperacillin–Tazobactam: A Retrospective Study. The Canadian Journal of Hospital Pharmacy. 68(5). 386–94. 3 indexed citations
12.
Lee, Colin, Sandra A N Walker, Nick Daneman, et al.. (2014). Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital. Journal of Epidemiology and Global Health. 5(2). 143–143. 24 indexed citations
13.
Palmay, Lesley, Marion Elligsen, Sandra A N Walker, et al.. (2014). Hospital-wide Rollout of Antimicrobial Stewardship: A Stepped-Wedge Randomized Trial. Clinical Infectious Diseases. 59(6). 867–874. 39 indexed citations
14.
Schultz, Laura, Sandra A N Walker, Marion Elligsen, et al.. (2013). Identification of predictors of early infection in acute burn patients. Burns. 39(7). 1355–1366. 40 indexed citations
15.
Walker, Sandra A N, et al.. (2013). Determination of Tobramycin Pharmacokinetics in Burn Patients to Evaluate the Potential Utility of Once-Daily Dosing in this Population. Journal of Burn Care & Research. 35(4). e240–e249. 5 indexed citations
16.
Elligsen, Marion, Sandra A N Walker, Ruxandra Pinto, et al.. (2012). Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis. Infection Control and Hospital Epidemiology. 33(4). 354–361. 151 indexed citations
17.
Elligsen, Marion, Sandra A N Walker, Andrew E. Simor, & Nick Daneman. (2012). Prospective Audit and Feedback of Antimicrobial Stewardship in Critical Care: Program Implementation, Experience, and Challenges. The Canadian Journal of Hospital Pharmacy. 65(1). 31–6. 57 indexed citations
18.
Elligsen, Marion, et al.. (2010). Optimizing initial vancomycin dosing in burn patients. Burns. 37(3). 406–414. 22 indexed citations
19.
Walker, Sandra A N, et al.. (2009). Mortality in a Heterogeneous Population of Low‐Risk Febrile Neutropenic Patients Treated Initially with Cefazolin and Tobramycin. Canadian Journal of Infectious Diseases and Medical Microbiology. 20(4). e145–52. 1 indexed citations
20.
Walker, Sandra A N, et al.. (2006). Management of Community-Acquired Pneumonia at a Tertiary-Care Teaching Hospital. The Canadian Journal of Hospital Pharmacy. 59(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026